I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Immunotherapy in Lung Cancer: Treatment After IO Cessation.
Immunotherapy is now a standard of care for first-line and eventually salvage therapy in patients with stage IV NSCLC and as adjuvant after RT-CT for stage III NSCLC. The aim of the study is determining the therapeutic landscape and the reason for immunotherapy cessation.
immunomodulators
chemoradiotherapy
salvage therapy
adjuvant
stage iv non-small cell lung cancer
- 0 views
- 19 Feb, 2024